AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Johnson & Johnson at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Johnson & Johnson brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 817, MR7. Its session covers biomarker discovery and selection across genitourinary cancers and the part pathology plays in that pathway. The company's medicines span oncology, immunology, neuroscience and cardiovascular disease.
| Organization | AMP 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
Johnson & Johnson Innovative Medicine develops medicines in oncology, immunology, neuroscience, cardiovascular disease, pulmonary hypertension and retina. | Booth Exhibiting at Booth 817, MR7 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Platinum Partner Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. |
Find decision makers at Johnson & Johnson
Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction